• 1. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 2. Aggregation-induced chiroptical generation and photoinduced switching of achiral azobenzene-alt-fluorene copolymer endowed with left- and right-handed helical polysilanes?
  Hailing Chen,Lu Yin,Meng Liu,Laibing Wang,Michiya Fujiki,Wei Zhang RSC Adv., 2019,9, 4849-4856
• 3. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 4. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 5. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzothiazoles Benzothiazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzothiazoles

Introduction to 6-Ethyl-benzothiazol-2-ylamine (CAS No. 21224-16-8)

6-Ethyl-benzothiazol-2-ylamine, identified by the Chemical Abstracts Service Number (CAS No.) 21224-16-8, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This compound belongs to the benzothiazole class, a structural motif widely recognized for its diverse biological activities and utility in drug discovery. The presence of an ethyl group at the 6-position and an amine substituent at the 2-position of the benzothiazole core imparts unique chemical and pharmacological properties, making it a promising candidate for further exploration in synthetic chemistry and therapeutic applications.

The benzothiazole scaffold is a fused ring system consisting of a benzene ring and a thiazole ring, both of which are rich in nitrogen and sulfur atoms. These elements contribute to the compound's ability to interact with biological targets such as enzymes and receptors, often leading to inhibitory or modulatory effects. The amine functional group at the 2-position of 6-Ethyl-benzothiazol-2-ylamine is particularly noteworthy, as it can participate in hydrogen bonding interactions, enhancing binding affinity to biological macromolecules. This feature makes the compound a valuable intermediate in the synthesis of more complex molecules designed for targeted therapeutic action.

In recent years, there has been a surge in research focused on developing novel heterocyclic compounds with potential pharmaceutical applications. Among these, benzothiazole derivatives have emerged as a prominent class of molecules due to their broad spectrum of biological activities. Studies have demonstrated that compounds containing the benzothiazole moiety exhibit properties ranging from antimicrobial and anti-inflammatory effects to anticancer and antiviral activities. The specific substitution pattern, as seen in 6-Ethyl-benzothiazol-2-ylamine, can fine-tune these properties, making it possible to develop highly selective agents with minimal off-target effects.

One of the most compelling aspects of 6-Ethyl-benzothiazol-2-ylamine is its versatility as a building block in medicinal chemistry. The compound can be further modified through various chemical reactions, such as functional group interconversions, coupling reactions, and derivatization strategies, to generate novel analogs with enhanced pharmacological profiles. For instance, researchers have explored its use in synthesizing kinase inhibitors, which are critical in treating cancers and inflammatory diseases. The ability to modify the benzothiazole core while retaining its core structural features allows for rapid optimization of lead compounds.

The synthesis of 6-Ethyl-benzothiazol-2-ylamine typically involves multi-step organic reactions starting from commercially available precursors. Common synthetic routes include cyclization reactions to form the benzothiazole ring system followed by selective functionalization at the 2- and 6-positions. Advances in synthetic methodologies have enabled more efficient and scalable production processes, making it feasible to produce larger quantities of this compound for research and development purposes. Additionally, green chemistry principles have been increasingly applied to these synthetic routes, reducing waste and improving atom economy.

From a computational chemistry perspective, 6-Ethyl-benzothiazol-2-ylamine has been studied using various modeling techniques to predict its interactions with biological targets. Molecular docking simulations have been particularly useful in identifying potential binding sites on proteins relevant to drug development. These studies often reveal that the amine group at the 2-position plays a crucial role in stabilizing interactions with target enzymes or receptors through hydrogen bonding networks. Such insights are invaluable for designing next-generation drugs with improved efficacy and selectivity.

The pharmacological evaluation of 6-Ethyl-benzothiazol-2-ylamine has yielded promising results in preclinical studies. In vitro assays have shown that this compound exhibits inhibitory activity against several enzymes implicated in disease pathways, including those involved in cancer progression and inflammation. For example, preliminary data suggest that derivatives of this compound may disrupt signaling pathways critical for tumor growth by inhibiting key kinases or modulating transcription factor activity. While these findings are encouraging, further research is needed to fully elucidate its mechanism of action and therapeutic potential.

In conclusion,6-Ethyl-benzothiazol-2-ylamine (CAS No. 21224-16-8) represents an intriguing molecule with significant potential in pharmaceutical research. Its unique structural features, combined with its versatility as a synthetic intermediate, make it a valuable tool for developing novel therapeutic agents. As our understanding of biological systems continues to evolve,6-Ethyl-benzothiazol-2-ylamine may play a pivotal role in addressing unmet medical needs across various therapeutic areas.

• 131395-10-3(2-Amino-6-(tert-butyl)benzothiazole)
• 235101-29-8(6-(2-methylbutan-2-yl)-1,3-benzothiazol-2-amine)
• 32895-14-0(6-(propan-2-yl)-1,3-benzothiazol-2-amine)
• 83777-92-8(2-Benzothiazolamine,5,6-diethyl-)
• 191719-16-1(6-pentyl-1,3-benzothiazol-2-amine)
• 2536-91-6(6-methyl-1,3-benzothiazol-2-amine)
• 90180-67-9(2-Benzothiazolamine, 6-methyl-, hydrobromide (1:1))
• 383131-47-3(6-(butan-2-yl)-1,3-benzothiazol-2-amine)
• 56896-76-5(2-Benzothiazolamine,6-methyl-, hydrochloride (1:1))
• 107726-13-6(6-propyl-1,3-benzothiazol-2-amine)